Shnayder, N.A.,
Novitsky, M.A.,
Neznanov, N.G.,
Limankin, O.V.,
Asadullin, A.R.,
Petrov, A.V.,
Dmitrenko, D.V.,
Narodova, E.A.,
Popenko, N.V.,
Nasyrova, R.F. (2022) to the general population. The
comorbidity between schizophrenia and depression suggests a potential coincidence
Spasov, AA,
Kucheryavenko, AF,
Khaliullin, FA,
Gurova, NA,
Sirotenko, VS,
Samorodov, AV,
Gaidukova, KA,
Pavlov, VN (2022) comorbidities and with isoproterenol-induced myocardial infarction. In animals without
comorbidities, Angipur
Tyurin, A.V.,
Salimgareeva, M.K.,
Miniakhmetov, I.R.,
Khusainova, R.I.,
Samorodov, A.,
Pavlov, V.N.,
Kzhyshkowska, J. (2022) parameters and cardiovascular
pathology history. We identified that a decrease in the absolute number of T
Yalaev, Bulat,
Tyurin, Anton,
Prokopenko, Inga,
Karunas, Aleksandra,
Khusnutdinova, Elza,
Khusainova, Rita (2022) fracture risk and low BMD in a
comorbid condition with 85% accuracy (AUC = 0.850; OR (95% CI) = 6.6 (4